Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
Silvestri, Guido, Lévy, Yves
, Lacabaratz, Christine, Ellefsen-Lavoie, Kim, Stöhr, Wolfgang, Lelièvre, Jean-Daniel, Bart, Pierre-Alexandre, Launay, Odile, Weber, Jonathan, Salzberger, Bernd, Wiedemann, Aurélie, Surenaud, Mathieu, Koelle, David M., Wolf, Hans, Wagner, Ralf, Rieux, Véronique, Montefiori, David C., Yates, Nicole L., Tomaras, Georgia D., Gottardo, Raphael, Mayer, Bryan, Ding, Song, Thiébaut, Rodolphe, McCormack, Sheena, Chêne, Geneviève and Pantaleo, Giuseppe
(2020)
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
PLOS Pathogens 16 (6), e1008522.
Date of publication of this fulltext: 11 Oct 2021 12:47
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | PLOS Pathogens | ||||
| Publisher: | PLOS | ||||
|---|---|---|---|---|---|
| Place of Publication: | SAN FRANCISCO | ||||
| Volume: | 16 | ||||
| Number of Issue or Book Chapter: | 6 | ||||
| Page Range: | e1008522 | ||||
| Date | 2020 | ||||
| Institutions | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identification Number |
| ||||
| Keywords | IMMUNE-RESPONSES; BOOST VACCINE; I TRIAL; IMMUNOGENICITY; SAFETY; MULTIANTIGEN; NYVAC-PF7; CANDIDATE; MACAQUES; ANKARA; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49969 |
Export bibliographical data
Owner only: item control page
Article Level Metrics (PLOS)
Article Level Metrics (PLOS)